SOD1 and amyotrophic lateral sclerosis: For example, the most clinically promising therapeutics for SOD1-associated ALS are antisense oligonucleotides (84), which bind to and enhance the degradation of SOD1 mRNA, effectively reducing the concentration of SOD1 within a cell.